These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37777511)

  • 21. C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation.
    Li C; Peng Q; Wan X; Sun H; Tang J
    J Cell Sci; 2017 Oct; 130(20):3496-3506. PubMed ID: 28851805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.
    Liang YC; Lee CC; Yao YL; Lai CC; Schmitz ML; Yang WM
    Sci Rep; 2016 May; 6():26509. PubMed ID: 27211601
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
    Hofmann S; Plank V; Groitl P; Skvorc N; Hofmann K; Luther J; Ko C; Zimmerman P; Bruss V; Stadler D; Carpentier A; Rezk S; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2023 Jun; 11(3):e0044623. PubMed ID: 37199632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A role for PML and the nuclear body in genomic stability.
    Zhong S; Hu P; Ye TZ; Stan R; Ellis NA; Pandolfi PP
    Oncogene; 1999 Dec; 18(56):7941-7. PubMed ID: 10637504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53.
    Sung KS; Lee YA; Kim ET; Lee SR; Ahn JH; Choi CY
    Exp Cell Res; 2011 Apr; 317(7):1060-70. PubMed ID: 21192925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.
    Schilling EM; Scherer M; Reuter N; Schweininger J; Muller YA; Stamminger T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arkadia, a novel SUMO-targeted ubiquitin ligase involved in PML degradation.
    Erker Y; Neyret-Kahn H; Seeler JS; Dejean A; Atfi A; Levy L
    Mol Cell Biol; 2013 Jun; 33(11):2163-77. PubMed ID: 23530056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
    J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of SUMO-SIM Interaction on the ICP0-Mediated Degradation of PML Isoform II and Its Associated Proteins in Herpes Simplex Virus 1 Infection.
    Jan Fada B; Kaadi E; Samrat SK; Zheng Y; Gu H
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32295906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promyelocytic leukemia nuclear body-like structures can assemble in mouse oocytes.
    Udagawa O; Kato-Udagawa A; Hirano S
    Biol Open; 2022 Jun; 11(6):. PubMed ID: 35579421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Author Correction: A CK2 and SUMO-dependent, PML NB-involved regulatory mechanism controlling BLM ubiquitination and G-quadruplex resolution.
    Liu S; Atkinson E; Paulucci-Holthauzen A; Wang B
    Nat Commun; 2024 Feb; 15(1):1077. PubMed ID: 38316763
    [No Abstract]   [Full Text] [Related]  

  • 32. On the Prevalence and Roles of Proteins Undergoing Liquid-Liquid Phase Separation in the Biogenesis of PML-Bodies.
    Silonov SA; Mokin YI; Nedelyaev EM; Smirnov EY; Kuznetsova IM; Turoverov KK; Uversky VN; Fonin AV
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells.
    Hirano S; Udagawa O; Kobayashi Y; Kato A
    Toxicol Appl Pharmacol; 2018 Dec; 360():150-159. PubMed ID: 30292834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of Smyd1 in endothelial cells is controlled by PML-dependent SUMOylation upon cytokine stimulation.
    Becker S; Steinemann G; Karle W; Roos K; Liem CH; Muralikumar S; Volkamer A; Munz B; Zakrzewicz A; Berkholz J
    Biochem J; 2021 Jan; 478(1):217-234. PubMed ID: 33241844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
    Engelhardt OG; Ullrich E; Kochs G; Haller O
    Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
    Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
    J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetylation of SUMO1 Alters Interactions with the SIMs of PML and Daxx in a Protein-Specific Manner.
    Mascle XH; Gagnon C; Wahba HM; Lussier-Price M; Cappadocia L; Sakaguchi K; Omichinski JG
    Structure; 2020 Feb; 28(2):157-168.e5. PubMed ID: 31879127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manipulating PML SUMOylation via Silencing UBC9 and RNF4 Regulates Cardiac Fibrosis.
    Liu Y; Zhao D; Qiu F; Zhang LL; Liu SK; Li YY; Liu MT; Wu D; Wang JX; Ding XQ; Liu YX; Dong CJ; Shao XQ; Yang BF; Chu WF
    Mol Ther; 2017 Mar; 25(3):666-678. PubMed ID: 28143738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
    Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
    Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.